140 related articles for article (PubMed ID: 30747077)
1. Antibacterial Evaluation of Novel Substituted Cycloheptaindoles in Staphylococcus and Enterococcus Strains.
Hilgeroth A; Yasrebi K; Suzen S; Hertlein T; Ohlsen K; Lalk M
Med Chem; 2019; 15(8):833-839. PubMed ID: 30747077
[TBL] [Abstract][Full Text] [Related]
2. Novel effective antibacterial small-molecules against
Yasrebi K; Schade N; Adeniyi ET; Wecklein B; Ymeraj A; Hertlein T; Ohlsen K; Suzen S; Lalk M; Ströhl D; Hilgeroth A
Future Med Chem; 2020 Jul; 12(13):1205-1211. PubMed ID: 32515228
[No Abstract] [Full Text] [Related]
3. Discovery of bisindolyl-substituted cycloalkane-anellated indoles as novel class of antibacterial agents against S. aureus and MRSA.
El-Sayed MT; Suzen S; Altanlar N; Ohlsen K; Hilgeroth A
Bioorg Med Chem Lett; 2016 Jan; 26(1):218-21. PubMed ID: 26590101
[TBL] [Abstract][Full Text] [Related]
4. Novel Effective Small-Molecule Antibacterials against Enterococcus Strains.
Ashraf K; Yasrebi K; Hertlein T; Ohlsen K; Lalk M; Hilgeroth A
Molecules; 2017 Dec; 22(12):. PubMed ID: 29232858
[No Abstract] [Full Text] [Related]
5. Antistaphylococcal evaluation of indole-naphthalene hybrid analogs.
Ashraf K; Yasrebi K; Adeniyi ET; Hertlein T; Ohlsen K; Lalk M; Erdmann F; Hilgeroth A
Drug Des Devel Ther; 2019; 13():275-283. PubMed ID: 30666089
[TBL] [Abstract][Full Text] [Related]
6. Indole-based derivatives as potential antibacterial activity against methicillin-resistance Staphylococcus aureus (MRSA).
Qin HL; Liu J; Fang WY; Ravindar L; Rakesh KP
Eur J Med Chem; 2020 May; 194():112245. PubMed ID: 32220687
[TBL] [Abstract][Full Text] [Related]
7. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds.
Yamamoto Y; Kurazono M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1626-8. PubMed ID: 17254785
[TBL] [Abstract][Full Text] [Related]
8. Novel synthetic bis-indolic derivatives with antistaphylococcal activity, including against MRSA and VISA strains.
Caspar Y; Jeanty M; Blu J; Burchak O; Le Pihive E; Maigre L; Schneider D; Jolivalt C; Paris JM; Hequet A; Minassian F; Denis JN; Maurin M
J Antimicrob Chemother; 2015; 70(6):1727-37. PubMed ID: 25691323
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
Hu L; Kully ML; Boykin DW; Abood N
Bioorg Med Chem Lett; 2009 Aug; 19(16):4626-9. PubMed ID: 19589676
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
Burchak ON; Pihive EL; Maigre L; Guinchard X; Bouhours P; Jolivalt C; Schneider D; Maurin M; Giglione C; Meinnel T; Paris JM; Denis JN
Bioorg Med Chem; 2011 May; 19(10):3204-15. PubMed ID: 21515059
[TBL] [Abstract][Full Text] [Related]
11. Novel Small-Molecule Hybrid-Antibacterial Agents against
Gehrmann R; Hertlein T; Hopke E; Ohlsen K; Lalk M; Hilgeroth A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011293
[TBL] [Abstract][Full Text] [Related]
12. New fluorescent rosamine chelator showing promising antibacterial activity against Gram-positive bacteria.
Novais Â; Moniz T; Rebelo AR; Silva AMG; Rangel M; Peixe L
Bioorg Chem; 2018 Sep; 79():341-349. PubMed ID: 29807207
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of a novel series of 3-bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives--an extended structure-activity relationship study.
Mahboobi S; Eichhorn E; Winkler M; Sellmer A; Möllmann U
Eur J Med Chem; 2008 Mar; 43(3):633-56. PubMed ID: 17624634
[TBL] [Abstract][Full Text] [Related]
14. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
Seefeld MA; Miller WH; Newlander KA; Burgess WJ; DeWolf WE; Elkins PA; Head MS; Jakas DR; Janson CA; Keller PM; Manley PJ; Moore TD; Payne DJ; Pearson S; Polizzi BJ; Qiu X; Rittenhouse SF; Uzinskas IN; Wallis NG; Huffman WF
J Med Chem; 2003 Apr; 46(9):1627-35. PubMed ID: 12699381
[TBL] [Abstract][Full Text] [Related]
15. Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens.
Jarvest RL; Berge JM; Berry V; Boyd HF; Brown MJ; Elder JS; Forrest AK; Fosberry AP; Gentry DR; Hibbs MJ; Jaworski DD; O'Hanlon PJ; Pope AJ; Rittenhouse S; Sheppard RJ; Slater-Radosti C; Worby A
J Med Chem; 2002 May; 45(10):1959-62. PubMed ID: 11985462
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles.
Tiwari RK; Singh D; Singh J; Yadav V; Pathak AK; Dabur R; Chhillar AK; Singh R; Sharma GL; Chandra R; Verma AK
Bioorg Med Chem Lett; 2006 Jan; 16(2):413-6. PubMed ID: 16246547
[TBL] [Abstract][Full Text] [Related]
18. Novel Small-molecule Antibacterials against Gram-positive Pathogens of
Seethaler M; Hertlein T; Wecklein B; Ymeraj A; Ohlsen K; Lalk M; Hilgeroth A
Antibiotics (Basel); 2019 Nov; 8(4):. PubMed ID: 31684039
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.
Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796
[TBL] [Abstract][Full Text] [Related]
20. Development of novel indole-quinoline hybrid molecules targeting bacterial proton motive force.
Seo J; Kim JH; Ko N; Kim J; Moon K; Kim IS; Lee W
J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38678002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
